Friday, July 17, 2026

Talc Intake Dominates a Firm-Concentrated MDL Day

Yesterday's 82-case intake concentrated around established consumer-product proceedings, with talc supplying the dominant volume and a small group of firms shaping every top-five docket. Johnson & Johnson Talcum Powder (2738) produced 32 filings, led by The Miller Firm LLC's 14 and The Smith Law Firm PLLC's nine, turning the day into a focused talc intake rather than a broad market-wide surge. The next tier stayed selective: Hair Relaxer (3060) added nine filings through Johnson Law Group (two) and Babin Law LLC (one), while Aqueous Film-Forming Foams (2873) drew four, all from Clancy Fleishman LLP. Medical-device and platform activity arrived in smaller, targeted packets, with Paragard IUD (2974) receiving three filings from KRA Legal PC and Susen Law Group, one apiece, and Social Media Adolescent Addiction (3047) adding three behind Levin Papantonio's two and Motley Rice's one. The dispersion shows disciplined repeat filing rather than a new multi-docket wave. See the full filing feed and firm-level breakdowns here.

Delaware Zantac Summary-Judgment Order

On April 14, 2026, Delaware Superior Court granted summary judgment in favor of defendants in In re: Zantac (Ranitidine) Litigation as to complaints filed on or before December 1, 2025. The state-court ruling is distinct from the federal Zantac MDL in the Southern District of Florida, where the court dismissed the general-causation claims after its December 2022 Daubert ruling. That federal dismissal is currently on appeal in the Eleventh Circuit; the Delaware ruling does not revive federal merits proceedings.

Copper-IUD Case Series Adds Related Clinical Research

On July 17, 2026, Nikita Vijay, Anjanee Pathak, and Anuja Bhalerao published Hysteroscopic Retrieval of Retained and Fractured Copper Intrauterine Devices: A Case Series of Three Patients and Literature Review in Cureus. The three-patient series described hysteroscopic retrieval of retained copper-T fragments after incomplete removal and of a fractured device with embedded fragments. Although the paper addresses generic copper-T devices rather than identifying Paragard, it is related clinical research for Paragard IUD (2974) and its fracture-and-retention allegations. The single-centre retrospective series does not establish a product defect or causation, and it does not resolve an individual claim in the federal litigation.